trimethyloxamine has been researched along with HIV Infections in 11 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Montrucchio, C | 1 |
| De Nicolò, A | 1 |
| D'Ettorre, G | 1 |
| D'Ascenzo, F | 1 |
| Lazzaro, A | 1 |
| Tettoni, M | 1 |
| D'Avolio, A | 1 |
| Bonora, S | 1 |
| Celani, L | 1 |
| Di Perri, G | 1 |
| Calcagno, A | 1 |
| Hove-Skovsgaard, M | 1 |
| Gaardbo, JC | 1 |
| Kolte, L | 1 |
| Winding, K | 1 |
| Seljeflot, I | 1 |
| Svardal, A | 2 |
| Berge, RK | 3 |
| Gerstoft, J | 1 |
| Ullum, H | 1 |
| Trøseid, M | 5 |
| Nielsen, SD | 4 |
| Haissman, JM | 2 |
| Haugaard, AK | 1 |
| Ostrowski, SR | 1 |
| Hov, JR | 2 |
| Missailidis, C | 1 |
| Neogi, U | 1 |
| Stenvinkel, P | 1 |
| Nowak, P | 1 |
| Bergman, P | 1 |
| Shan, Z | 1 |
| Clish, CB | 1 |
| Hua, S | 1 |
| Scott, JM | 1 |
| Hanna, DB | 1 |
| Burk, RD | 1 |
| Haberlen, SA | 2 |
| Shah, SJ | 1 |
| Margolick, JB | 2 |
| Sears, CL | 2 |
| Post, WS | 2 |
| Landay, AL | 1 |
| Lazar, JM | 1 |
| Hodis, HN | 1 |
| Anastos, K | 1 |
| Kaplan, RC | 1 |
| Qi, Q | 1 |
| Kehrmann, J | 1 |
| Menzel, J | 1 |
| Saeedghalati, M | 1 |
| Obeid, R | 1 |
| Schulze, C | 1 |
| Holzendorf, V | 1 |
| Farahpour, F | 1 |
| Reinsch, N | 1 |
| Klein-Hitpass, L | 1 |
| Streeck, H | 1 |
| Hoffmann, D | 1 |
| Buer, J | 1 |
| Esser, S | 1 |
| Sinha, A | 1 |
| Ma, Y | 1 |
| Scherzer, R | 1 |
| Rahalkar, S | 1 |
| Neilan, BD | 1 |
| Crane, H | 1 |
| Drozd, D | 1 |
| Martin, J | 1 |
| Deeks, SG | 1 |
| Hunt, P | 1 |
| Hsue, PY | 1 |
| Srinivasa, S | 1 |
| Fitch, KV | 1 |
| Lo, J | 1 |
| Kadar, H | 1 |
| Knight, R | 1 |
| Wong, K | 1 |
| Abbara, S | 1 |
| Gauguier, D | 1 |
| Capeau, J | 1 |
| Boccara, F | 1 |
| Grinspoon, SK | 1 |
| Knudsen, A | 2 |
| Hoel, H | 1 |
| Kjær, A | 2 |
| Kristoffersen, US | 1 |
| Katzenstein, TL | 1 |
| Ueland, T | 1 |
| Aukrust, P | 1 |
| Lebech, AM | 2 |
| Miller, PE | 1 |
| Brown, TT | 1 |
| DiDonato, JA | 1 |
| Hazen, SL | 1 |
| Witt, MD | 1 |
| Kingsley, LA | 1 |
| Palella, FJ | 1 |
| Budoff, M | 1 |
| Jacobson, LP | 1 |
| Christensen, TE | 1 |
| Thorsteinsson, K | 1 |
| Ghotbi, AA | 1 |
| Hasbak, P | 1 |
| Berge, R | 1 |
| Ripa, RS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk, New Cardiovascular Events and the Cardiovascular Diseases in HIV-infected Patients: 15 Year Follow up[NCT04330287] | 2,000 participants (Anticipated) | Observational | 2020-05-11 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 other studies available for trimethyloxamine and HIV Infections
| Article | Year |
|---|---|
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation.
Topics: Adult; Anti-Retroviral Agents; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Intima- | 2020 |
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure L | 2017 |
Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Topics: Adult; Betaine; Biomarkers; Blood Platelets; Cardiovascular Diseases; Carnitine; Choline; Cross-Sect | 2017 |
The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages.
Topics: Adult; Aged; Bacterial Translocation; Cardiovascular Diseases; Cluster Analysis; DNA, Bacterial; DNA | 2018 |
Gut Microbial-Related Choline Metabolite Trimethylamine-N-Oxide Is Associated With Progression of Carotid Artery Atherosclerosis in HIV Infection.
Topics: Atherosclerosis; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Choline; Female; Gastrointes | 2018 |
Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart Disease.
Topics: Adult; Aged; Bacteroides; Biodiversity; Coronary Disease; Female; Gastrointestinal Microbiome; HIV I | 2019 |
Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected Adults.
Topics: Adult; Antiretroviral Therapy, Highly Active; Atherosclerosis; Betaine; Carnitine; Carotid Artery Di | 2019 |
Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.
Topics: Choline; Coronary Artery Disease; Dysbiosis; Female; HIV Infections; Humans; Intestinal Diseases; Ma | 2015 |
Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection.
Topics: Adolescent; Adult; Aged; Biomarkers; Case-Control Studies; Cohort Studies; Coronary Artery Disease; | 2016 |
Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus.
Topics: Coronary Stenosis; Gastrointestinal Microbiome; HIV Infections; HIV Seroprevalence; Humans; Male; Me | 2016 |
Microbiota-Dependent Marker TMAO is Not Associated With Decreased Myocardial Perfusion in Well-Treated HIV-Infected Patients as Assessed by 82Rubidium PET/CT.
Topics: Biomarkers; Cardiovascular System; Coronary Disease; Cross-Sectional Studies; Female; Gastrointestin | 2016 |